Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,645.00
Bid: 1,645.00
Ask: 1,645.50
Change: 30.00 (1.86%)
Spread: 0.50 (0.03%)
Open: 1,631.00
High: 1,653.00
Low: 1,630.50
Prev. Close: 1,615.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Two votes cast to start BoE tapering

Thu, 23rd Sep 2021 12:08

(Alliance News) - Stock prices in London were slightly higher, even as both the US and UK central banks edged toward tapering economic stimulus.

The Monetary Policy Committee of the Bank of England voted by a majority of 7-2 to maintain quantitative easing at the current pace of GBP895 billion. Dave Ramsden and Michael Saunders cast dissenting votes to cut gilt QE to GBP840 billion. All 9 MPC members voted to keep interest rates unchanged, with the Bank Rate at 0.10%.

The pound was quoted at USD1.3674 on Thursday after the midday decision by the BoE, up from USD1.3659 at the London equities close Wednesday.

The FTSE 100 index was up 8.36 points, or 0.1%, at 7,091.71. The mid-cap FTSE 250 index was up 53.25 points, 0.2%, at 23,837.79. The AIM All-Share index was up 6.03 points, 0.5%, at 1,274.16.

The Cboe UK 100 index was up 0.2% at 705.40. The Cboe 250 was flat at 21,622.30. The Cboe Small Companies was 0.1% lower at 15,528.00.

In mainland Europe, the CAC 40 stock index in Paris and the DAX 40 index in Frankfurt were both up 0.8%.

Analysts at ActivTrades said investors welcomed Wednesday's policy statement from the US Fed. "[Chair] Jerome Powell confirmed tapering is on its way and will start sooner than expected. The Fed added it wouldn't need 'a very strong jobs report to go ahead with taper', which can be seen as a message to the market that the party will finally come to an end, mentioning November as a potentially good moment to scale back asset purchases.

"However, the market hasn't bought the rumour of any potential tapering to come but instead preferred to stick to the reality of the current extremely dovish environment that will remain for some time at least."

In the FTSE 100, Rolls-Royce was the best performer, up 3.4% at 126.26 pence after Berenberg raised its price target on the stock to 160p from 150p and reiterated its Buy rating.

Reckitt Benckiser was up 0.3%. The hygiene and home cleaning products firm said trading since its half-year results in July has been in line with management expectations.

Reckitt said it continued to be confident in delivering 2021 like-for-like net revenue growth in a range of 0% to 0.2% and an adjusted operating profit margin between 22.7% to 23.2%. Reckitt posted like-for-like net revenue growth of 12% and an adjusted operating profit margin of 23.6% for 2020.

Royal Mail shares were flat after the UK postal operator lifted its profit guidance and expressing confidence in its outlook.

In the five months to the end of August, total revenue grew by 8.2% year-on-year and by 18% compared to the same period in 2019.

In the domestic Royal Mail arm, revenue increased by 7.2% year-on-year and by 12% against the same period in 2019. The company said domestic parcel volumes are up by around third compared to pre-Covid levels and that it is maintaining its share of the UK market.

At its GLS international logistics unit, revenue rose 9.3% from the same time last year and by 31% versus the same period in 2019.

Looking ahead, Royal Mail expects adjusted operating profit for the six months to the end of September to be around GBP395 million to GBP400 million, with at least GBP230 million from the Royal Mail unit. This compares to profit of just GBP37 million a year ago, and would even exceed the GBP165 million posted for the same period in 2019.

At the other end of the large-caps, Entain was the worst performer, down 2.8%. The gambling firm was giving back some of its strong recent gains after it received a takeover approach from US peer DraftKings. The stock is up 22% this week alone.

Hargreaves Lansdown was down 2.0%, after the wealth manager's shares went ex-dividend, meaning new buyers no longer qualify for the latest payout.

GlaxoSmithKline was down 0.1% after Bloomberg reported on Wednesday that activist investor Bluebell Capital Partners has bought a stake in GlaxoSmithKline and criticised Chief Executive Officer Emma Walmsley.

In a letter seen by the news outlet, Bluebell called for a "thorough and robust process to identify the best (internal or external) candidate" to lead the company after it spins off its consumer division to focus on pharmaceuticals.

"The lack of Walmsley's industry knowledge was also very evident during the latest investor update," the letter said, echoing criticism from Elliott Investment Management.

Meanwhile, Marley Group confirmed its plans to list on London's Main Market, after saying earlier this month it was considering an initial public offering.

The Burton Upon Trent-based pitched roofing business did not disclose the number of shares to be issued, offer price or expected market capitalisation, but said it hopes to raise gross proceeds around GBP75 million. The IPO is likely to take place in October.

On the economic front, the UK private sector lost momentum in September with the rate of expansion in both output and new orders the weakest in seven months.

The IHS Markit-CIPS flash UK composite purchasing managers' index print was 54.1 points in September, below August's reading of 54.8.

The UK services PMI score was 54.6 points in September, down slightly from 55.0 in August and missed the market forecast, cited by FXStreet, of 55.0.

The UK manufacturing PMI reading was 56.3 points in September, sharply lower from 60.3 in August and missed the market estimate of 59.0.

All three UK PMI prints were the lowest seen in seven months.

"September's flash PMIs suggest that the economy is losing momentum a little faster than we originally anticipated, posing a downside risk to our view that the economy will return to its pre-pandemic level by November," commented analysts at Capital Economics.

The euro was priced at USD1.1715, down from USD1.1738.

A survey of eurozone business activity pointed to slower growth in September, Markit said, as bottlenecks curb activity and the input price gauge hit 21-year high. The flash headline composite purchasing managers' index fell sharply in September to 56.1 points from 59.0 points in August.

Any score above 50 represents growth, but the latest increase in business activity was the weakest since April, albeit still well above the survey's pre-pandemic long-run trend.

The flash services activity index read 56.3 points in September versus 59.0 points in August. The flash manufacturing output index fell back to 55.6 points in September from 59.0 points in August.

Against the Japanese yen, the dollar was trading at JPY109.87, up from JPY109.57.

Brent was quoted at USD75.94 a barrel Thursday at midday, higher against USD75.44 a barrel late Wednesday. Gold stood at USD1,771.22 an ounce, down from USD1,778.80.

US stock market futures were pointed to a higher open after the US Federal Reserve said the tapering of economic stimulus may "soon be warranted" as the economy edges closer to its employment and price stability goals.

The Dow Jones Industrial Average was called up 0.5%, the S&P 500 up 0.4%, and the Nasdaq Composite up 0.5%.

The Fed left its benchmark rate unchanged in the range of 0.00% to 0.25%. Chair Jerome Powell said the US economy has made progress towards the Fed's goals, and if things continue to advance at a speed that the Federal Reserve Open Market committee expects, a "moderation in the pace of asset purchases" may occur.

The Fed is currently buying at least USD80 billion in Treasury securities and USD40 billion in agency mortgage‑backed securities every month as part of its stimulus efforts.

Powell said that if the US economy continues to improve, "a gradual tapering process that concludes around the middle of next year is likely to be appropriate".

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
Today 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
3 Jun 2024 17:20

European shares kick-off June on a high note in anticipation of ECB rate cut

GSK tumbles as Zantac lawsuits allowed to proceed

*

Read more
3 Jun 2024 17:19

Pharma, energy stocks drag London's FTSE 100; ECB rate cut hopes cap losses

FTSE 100 down 0.2%, FTSE 250 up 0.8%

*

Read more
3 Jun 2024 17:00

LONDON MARKET CLOSE: FTSE 100 down amid shaky start in New York

(Alliance News) - The FTSE 100 in London closed lower on Monday, marking a mixed start to June, with GSK firmly at the bottom of the index.

Read more
3 Jun 2024 14:01

GSK immunotherapy bowel cancer drug works for 100% of patients

(Alliance News) - An immunotherapy drug could spare bowel cancer patients the need for surgery and chemotherapy after results showed it was effective in 100% of cases.

Read more
3 Jun 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 up, while Labour commits to defence

(Alliance News) - Stock prices in London were up at midday, after data from S&P Global signalled a return to growth for the UK manufacturing sector.

Read more
3 Jun 2024 09:08

TOP NEWS: GSK vows to appeal adverse Delaware court ruling on Zantac

(Alliance News) - GSK PLC on Monday said it will appeal a US court ruling that it should face jury trials relating to cases concerning the heartburn drug, Zantac.

Read more
3 Jun 2024 08:37

LONDON MARKET OPEN: Stocks up amid slew of manufacturing PMIs

(Alliance News) - Stock prices in London opened higher on Monday, ahead of local purchasing managers index data, and comparative prints from several other major global economies.

Read more
3 Jun 2024 08:00

LONDON BRIEFING: FTSE 100 seen up; GSK defends ranitidine cancer claim

(Alliance News) - Stocks in London are set to open higher on Monday, ahead of a data-heavy week, kicked off by a slew of manufacturing purchasing managers' index readings.

Read more
3 Jun 2024 07:30

GSK to appeal Delaware ruling on jury trials in Zantac cancer cases

(Sharecast News) - GSK shares were down almost 10% on Monday after a US court ruled that jury trials could hear expert witnesses in 70,000 cases brought by cancer sufferers claiming its Zantac heartburn drug caused their condition.

Read more
1 Jun 2024 21:35

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
1 Jun 2024 21:07

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
31 May 2024 17:45

US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label

May 31 (Reuters) - The U.S. Food and Drug Administration approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
31 May 2024 16:01

US FDA approves Moderna's RSV vaccine, its second marketed product

May 31 (Reuters) - The U.S. Food and Drug Administration has approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
30 May 2024 20:56

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 30 (Reuters) - A third U.S. dairy worker tested positive for bird flu after exposure to infected cows, and was the first to suffer respiratory symptoms, U.S. officials said on Thursday in the latest expansion of the outbreak. Bird flu has been found in dairy cattle in nine states. This second case in a Michigan dairy worker was found through increased testing of people and cows in the state following the April 1 identification of a case in a Texas farm worker. Here's what you need to know about the outbreak.

WHY IS H5N1 OR BIRD FLU A CONCERN?

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.